BMJ Impact Analytics available via OpenAthens

Last week healthcare knowledge provider, BMJ Group, and federated single sign-on services, OpenAthens, announced that OpenAthens' advanced authentication technology is now available on BMJ Impact Analytics.

BMJ Group says BMJ Impact Analytics joins the growing number of BMJ Group products that can be accessed via OpenAthens, including BMJ Journals and BMJ Best Practice. BMJ Group customers that support federated authentication can now offer their users a more simple and consistent access experience. Healthcare researchers across the world can move seamlessly between the BMJ Group suite of products with a single login. They can also access other subscribed medical resources that support the same standards-based authentication technology.

BMJ Impact Analytics is a tool available worldwide for tracking and sharing the real-world impact of medical and health research. Launched in 2023, it was developed in collaboration with start-up, Overton. ALPSP declared the new product the winner of its 2023 Award for Innovation in Publishing and it was also a finalist in OpenAthens’ 2024 UX Award.

BMJ Group says its integration with OpenAthens offers benefits on a global scale:

• Seamless access worldwide: Healthcare professionals can enjoy streamlined access to critical analytics and insights, enhancing their ability to improve healthcare outcomes.
• Security: With the increase in cyber-attacks in the education and research sector it is vital that medical and healthcare resources are kept safe. OpenAthens helps protect against this threat by working with publishers and library organisations to identify and act on any signs of misuse.
• Personalisation: Users can now benefit from personalisation features such as saved searches and recommendations whilst protecting their privacy.
• Enhanced efficiency: Increased efficiency with quick access to frequently updated evidence of real world impact, including citations in local guidelines and tools.

This tool supports academic institutions and funders in discovering where research has been cited in clinical guidance and health policies worldwide. BMJ Group says it does this by providing citations in context and showing the impact of research on patient care (citing BMJ Group’s clinical decision support tool, BMJ Best Practice).

Michelle Phillips, senior product manager at BMJ Group, shared her enthusiasm about this collaboration with OpenAthens: "Since launching in January 2023, user feedback has been the cornerstone of our product development. We are thrilled that organisations that support federated authentication can now access BMJ Impact Analytics through OpenAthens as this will enhance our users' experience. This partnership allows us to provide our customers with seamless access to the invaluable insights that BMJ Impact Analytics offers."

Ian Wareing, senior product manager at OpenAthens highlights the positive impact of seamless access: "Integrating OpenAthens' advanced authentication with BMJ Impact Analytics is a game-changer for medical organisations. The seamless access to critical analytics and insights allows healthcare professionals to enhance outcomes and efficiency effortlessly. This collaboration significantly supports our mission to remove barriers to knowledge and leads to better patient care by leveraging comprehensive data on medical research impact."

You can find out more about OpenAthens in our Publishing Services Directory.